Corporate Headquarters
Vector Laboratories, Inc.
6737 Mowry Ave
Newark, CA 94560
United States
STRADA / LYK5 contains a STE20-like kinase domain, but lacks several residues that are critical for catalytic activity, so it is termed a 'pseudokinase'. The protein forms a heterotrimeric complex with serine/threonine kinase 11 (STK11, also known as LKB1) and the scaffolding protein calcium binding protein 39 (CAB39, also known as MO25). The protein activates STK11 leading to the phosphorylation of both proteins and excluding STK11 from the nucleus. The protein is necessary for STK11-induced G1 cell cycle arrest. A mutation in this gene has been shown to result in polyhydramnios, megalencephaly, and symptomatic epilepsy (PMSE) syndrome. Multiple transcript variants encoding different isoforms have been found for this gene. Additional transcript variants have been described but their full-length nature is not known.
Gene Name: | STE20-related kinase adaptor alpha |
Family/Subfamily: | Protein kinase , STLK |
Synonyms: | STRADA, Protein kinase LYK5, LYK5, Stlk, NY-BR-96, PMSE, STE20-like pseudokinase, STE20-related adapter protein, STRAD, STRAD alpha |
Target Sequences: | NM_001003787 NP_001003787.1 Q7RTN6 |
If you do not find the reagent or information you require, please contact Customer.Support@LSBio.com to inquire about additional products in development.